DK306978A - Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner - Google Patents

Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner

Info

Publication number
DK306978A
DK306978A DK783069A DK306978A DK306978A DK 306978 A DK306978 A DK 306978A DK 783069 A DK783069 A DK 783069A DK 306978 A DK306978 A DK 306978A DK 306978 A DK306978 A DK 306978A
Authority
DK
Denmark
Prior art keywords
cyanaziridines
acyl
procedure
preparation
Prior art date
Application number
DK783069A
Other languages
English (en)
Inventor
H Berger
R Gall
W Kampe
U Bicker
R Kuhn
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK306978A publication Critical patent/DK306978A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/18Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42AMMUNITION; BLASTING
    • F42BEXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B3/00Blasting cartridges, i.e. case and explosive
    • F42B3/087Flexible or deformable blasting cartridges, e.g. bags or hoses for slurries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK783069A 1977-07-11 1978-07-07 Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner DK306978A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772731264 DE2731264A1 (de) 1977-07-11 1977-07-11 Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
DK306978A true DK306978A (da) 1979-01-12

Family

ID=6013651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK783069A DK306978A (da) 1977-07-11 1978-07-07 Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner

Country Status (26)

Country Link
US (1) US4267174A (da)
JP (1) JPS5436254A (da)
AT (1) AT356663B (da)
AU (2) AU519219B2 (da)
BE (1) BE868796A (da)
CA (1) CA1086309A (da)
CS (1) CS208656B2 (da)
DD (1) DD137710A5 (da)
DE (1) DE2731264A1 (da)
DK (1) DK306978A (da)
ES (1) ES471512A1 (da)
FI (1) FI782157A (da)
FR (1) FR2397403A1 (da)
GB (1) GB1594079A (da)
HU (1) HU179428B (da)
IL (1) IL55109A (da)
IT (1) IT1096910B (da)
LU (1) LU79937A1 (da)
NL (1) NL7807276A (da)
NO (1) NO782399L (da)
NZ (1) NZ187794A (da)
PL (1) PL126639B1 (da)
PT (1) PT68263A (da)
SE (1) SE7807642L (da)
SU (1) SU1077565A3 (da)
ZA (1) ZA783829B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2906603A1 (de) * 1979-02-21 1980-09-04 Boehringer Mannheim Gmbh N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
US4393000A (en) * 1979-12-12 1983-07-12 Mitsui Toatsu Chemicals, Inc. Cyclization process for producing aziridine-2-carboxylic acid or its salts
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
PT1599468E (pt) 2003-01-14 2008-01-14 Arena Pharm Inc Derivados de arilo e heteroarilo 1,2,3.-trissubstituídos comomoduladores do metabolismo, e profilaxia e tratamento dedesordens relacionadas tais como diabetes e hiperglicemia
US20070066590A1 (en) * 2003-02-24 2007-03-22 Jones Robert M Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
AR045047A1 (es) * 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CN101870690A (zh) * 2004-06-04 2010-10-27 艾尼纳制药公司 作为代谢调节剂的经取代芳基和杂芳基衍生物及其相关病症的预防和治疗
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
MX2008003634A (es) * 2005-09-16 2009-10-08 Arena Pharm Inc Moduladores del metabolismo y tratamiento de los trastornos metabolicos.
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
EP3242666A1 (en) 2015-01-06 2017-11-15 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
DK3310760T3 (da) 2015-06-22 2022-10-24 Arena Pharm Inc Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
LV15518A (lv) * 2019-02-18 2020-08-20 Latvijas Organiskās Sintēzes Institūts Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze
WO2021141507A1 (en) * 2020-01-10 2021-07-15 Uniwersytet Jagielloński Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use
EP4087651A1 (en) * 2020-01-10 2022-11-16 Uniwersytet Jagiellonski Aromatic sulphonamides derivatives that inhibits pdi a1, their synthesis and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD110492A1 (da) * 1974-03-21 1974-12-20
JPS5932772B2 (ja) * 1974-09-21 1984-08-10 旭光学工業 (株) 照射光走査装置
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans

Also Published As

Publication number Publication date
CA1086309A (en) 1980-09-23
SU1077565A3 (ru) 1984-02-29
FR2397403A1 (fr) 1979-02-09
AU519219B2 (en) 1981-11-19
BE868796A (fr) 1979-01-08
DE2731264A1 (de) 1979-02-01
LU79937A1 (de) 1980-02-14
NO782399L (no) 1979-01-12
PL208195A1 (da) 1980-03-24
PT68263A (de) 1978-08-01
ZA783829B (en) 1980-03-26
AT356663B (de) 1980-05-12
AU3782678A (en) 1980-01-10
IL55109A0 (en) 1978-09-29
IT7825474A0 (it) 1978-07-07
CS208656B2 (en) 1981-09-15
JPS5436254A (en) 1979-03-16
PL126639B1 (en) 1983-08-31
IT1096910B (it) 1985-08-26
US4267174A (en) 1981-05-12
DD137710A5 (de) 1979-09-19
NZ187794A (en) 1980-05-08
NL7807276A (nl) 1979-01-15
FI782157A (fi) 1979-01-12
AU3782578A (en) 1980-01-10
IL55109A (en) 1982-07-30
GB1594079A (en) 1981-07-30
HU179428B (en) 1982-10-28
SE7807642L (sv) 1979-03-14
ATA496478A (de) 1979-10-15
ES471512A1 (es) 1979-10-01

Similar Documents

Publication Publication Date Title
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK569678A (da) Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider
DK484677A (da) Fremgangsmaade til fremstilling af furokumariner
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK466878A (da) Fremgangsmaade til fremstilling af 0-methallyloxyphenol
DK398078A (da) Fremgangsmaade til fremstilling af sulfonylamidinforbindelser
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK154949C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK436978A (da) Fremgangsmaade til fremstilling af sarcosinoxidase
DK226678A (da) Fremgangsmaade til fremstilling af hexahydrogamma-carbolinforbindelser
DK577078A (da) Fremgangsmaade til fremstilling af trans-4a-aryloctahydro-1h-2-pyridiner
DK5778A (da) Femgangsmaade til fremstilling af 4-diphenylmethylen-1-hydroxybenzyl-piperidiner
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK339777A (da) Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner
DK383978A (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner
DK158976C (da) Fremgangsmaade til fremstilling af alfa-cyanobenzyl
DK206178A (da) Fremgangsmaade til fremstilling af 3-bromphthalid
DK195877A (da) Fremgangsmaade til fremstilling af di-n-propylacetonitril
DK147939C (da) Fremgangsmaade til fremstilling af di-n-propylacetamid
DK195678A (da) Fremgangsmaade til fremstilling af benzylpyrimidiner

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment